MAM
Future Generali India Insurance Company appoints Akshaya Kashyap as chief people officer
Mumbai: Future Generali India Insurance Company (FGII), has announced that it has appointed Akshaya Kashyap as the chief people officer of the organisation, effective 1 October, 2023. He has a rich and diverse experience in the Human Resource (HR) domain, spanning over 18 years, with almost a decade of that being with Future Generali.
Kashyap takes over from Sunil Wariar who superannuated from service in September this year. Previously, Akshaya served as a DGM HR in India Life (FGIL) before moving to FGII in February 2016. He also had an overseas stint with Generali Vietnam, which greatly developed and broadened his functional and management competence. Prior to joining Future Generali, he has worked in varied sectors including auto-ancillary, manufacturing and retail.
Commenting on the development, Future Generali India Insurance Company CEO & managing director Anup Rau said, “In alignment with our employee- centric philosophy, our primary focus is on promoting our dedicated current team members who have invested their time and energy in our organization when it comes to filling critical positions, rather than seeking external candidates. I am confident that Akshaya will build on the platform established by Sunil and further extend the company’s culture where employees from diverse backgrounds work collaboratively and in a cohesive manner. Sunil has played a stellar role over the last 14 years and has been instrumental in shaping the company’s HR policies and employee first approach. I would like to thank Sunil for his services and wish him the very best for the next phase of his life.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
